Improving QoL in Patients with Parkinson Disease
Differentiating Off Episodes in Parkinson Disease
Off Episodes in a 63-Year-Old Woman With Parkinson
Reviewing a Case of Parkinson Disease OFF Episodes
CMSC 2020 Day 1: Patricia Melville, Marijean Buhse, PhD, on Comorbidities and Critical Thinking About DMTs and Vaccines
Patricia Melville, NP-C, MSCN, and Marijean Buhse, PhD, NP-C, MSCN, present their lecture titled, "Comorbidities and MS: Critical Thinking About DMTs and Vaccines" as part of the 2020 CMSC Virtual Annual Meeting.
CMSC 2020 Day 1: Peter Calabresi, MD, on CNS Immune Responses in Progressive MS
Peter Calabresi, MD, delivers the Whitaker Lecture as part of the 2020 CMSC Virtual Annual Meeting.
CMSC 2020 Day 1: Amy Sullivan, PsyD, ABPP, on Science, Art, and Practice of Behavioral Medicine in MS
Amy Sullivan, PsyD, ABPP, presents her lecture titled, "Science, Art, and Practice of Behavioral Medicine" as part of the 2020 CMSC Virtual Annual Meeting.
CMSC 2020 Day 1: Brian Weinshenker, MD, on Emerging Treatment Options for NMOSD
Brian Weinshenker, MD presents his lecture titled, "Neuromyelitis Optica Spectrum Disorders: Emerging Treatment Options" as part of the 2020 CMSC Virtual Annual Meeting.
CMSC 2020 Day 1: Patricia Coyle, MD on Diagnosis, Clinical Course, and Long-Term Management of Progressive MS
Patricia Coyle, MD, delivers her lecture titled, "Progressive MS: Diagnosis, Clinical Course and Long-Term Management" as part of the 2020 CMSC Virtual Annual Meeting.
Optimizing Outcomes for Patients With MS
Ofatumumab for Relapsing MS
Treating Relapsing MS With Ocrelizumab
Ocrelizumab for Relapsing MS
Response to Cladribine Tablets in RRMS
Repository Corticotropin Injection for RRMS
Relapse Recovery and Outcomes in MS
Repository Corticotropin Injection for Relapsing MS
The Gut Microbiota and Risk of Relapse in MS
Goals of Therapy for Relapsing MS
Escalation Versus Induction Therapy in Relapsing Multiple Sclerosis
Steven Shook, MD: Managing Patients Via Telemedicine
The staff neurologist, Vice-Chair of Operations, and Quality Improvement Officer at Cleveland Clinic Neurological Institute detailed his experience managing patients with various conditions through a telemedicine platform.
Jennifer Frontera, MD: Reaction to COVID-19 Data
The professor of neurology at NYU Langone shares her thoughts on the clinical data that has been released so far on patients with COVID-19.
COVID-19 Stroke Recommendations, Nusinersen New SMA Results, Upcoming 2020 CMSC Virtual Annual Meeting
Neurology News Network for the week ending May 23, 2020.
Mark Freedman, MD: An Update on Stem Cell Research in MS
The director of the multiple sclerosis research unit at Ottawa Hospital discussed stem cell therapies being explored in multiple sclerosis, and which patients may be eligible for these treatments.
The Future of Multiple Sclerosis Management
Novel Oral Therapy for MS: AAN Data Updates
AAN 2020 Data Release: Ofatumumab for Relapsing MS
Treating Patients With MS During the COVID-19 Pandemic
MS Treatment Optimization During COVID-19
Multiple Sclerosis: Takeaways From AAN 2020